National Beef Additive Alert™ Reacts to UNL Zilmax Cattle Health Safety Study

July 17, 2014

Applauds USA Meat Processors for Stance

Springfield, Nebraska (PRWEB) July 17, 2014

Beef Additive Alert™ remains greatly concerned about animal welfare despite a small-scale University of Nebraska at Lincoln and USDA study finding “no noticeable detrimental effect” to Zilmax-fed cattle.

“The research reportedly involved a mere 20 heifers in an industry that processes 600,000 cattle per week,” notes Beef Additive Alert™ co-founder Harvey Dietrich.

The study also declined to examine consumer concerns about residues and overall beef quality. “We don’t think FDA-approved beta agonists belong in the meat industry at all. We are concerned about decreased quality and tenderness. We are in the beef business, not the chemical business,” said Dietrich.

"We know that the pharmaceutical industry has a history of funding university Ag research. We were not able to confirm if that is the case here,” said Beef Additive Alert’s Gerald Timmerman. Lead UNL researcher Ty Schmidt could not be reached for comment.

Reuters reported on August 13, 2013 that Merck Animal Health announced it was suspending Zilmax sales after reports surfaced of cattle in distress ranging from hoof problems to lameness after fed the FDA-approved performance enhancing drug Zilmax. The drug maker had intended to conduct an apparent large-scale animal welfare study this summer, but as the Wall Street Journal reported on July 14, 2014 industry reluctance has stalled the field evaluation.

“We applaud the USA’s largest beef processors for their continued integrity. We are very hopeful that the industry does not back down. They’re thinking about animal welfare and the consumer. So are we,” said Beef Additive Alert's Communications Director Susan Stern.

Beef Additive Alert™ is a national consumer awareness campaign founded by two veteran cattle ranchers who seek to preserve USA Beef quality, consistency and integrity.


Connect with Beef Additive Alert:




For the original version on PRWeb visit: http://www.prweb.com/releases/zilmax/ban/prweb12024957.htm

Source: prweb

comments powered by Disqus